Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Kuros Biosciences Logo
Kuros Biosciences Growth Score
33
CB Rank
680416
Heat Score
9
Kuros Biosciences is a public biopharmaceutical company focused on the development of targeted immunotherapies .
Founded
obfuscation
PublicPost-IPO Equity Schlieren, Zurich, Switzerland51-100 kurosbio.com/
Biotechnology
Hospital
Pharmaceutical
Overview

Kuros Biosciences
Total Funding
obfuscation
Growth Score
33
Heat Score
9

Total Funding
obfuscation
obfuscation
Post-IPO Equity raised
obfuscation
Growth Score33
-47 pts
in past quarter
Heat Score 9
-13 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Kuros Biosciences

CB Rank
680416
Kuros Biosciences is a public biopharmaceutical company focused on the development of targeted immunotherapies .
Founded
obfuscation
PublicPost-IPO Equity Schlieren, Zurich, Switzerland51-100 kurosbio.com/
Biotechnology
Hospital
Pharmaceutical

Funding Rounds

Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation
Series C
OBF
in
obfuscation

Key People

Details

Legal Name Kuros Biosciences AG
Also Known As Kuros Biosciences AG, cytos
Operating Status Active
Stock Symbol  SWX:KURN
Company Type For Profit
Founders  Wolfgang A. Renner
About the Company
Cytos is a public biopharmaceutical company focused on the development of targeted immunotherapies with a VLP B-cell vaccines platform and ongoing preclinical development programs based on the platform.
Phone Number 4117334644
Contact Email info@kuros.ch
Predictions & Insights

Growth Insight

See this Growth Insight
Kuros Biosciences is
Lorem
 to be growing
Top Contributing Factors
Financial Growth

Growth Prediction

See this Growth Prediction

Products & Services

MagnetOs Granules
A synthetic bone graft with needle-shaped surface technology designed to stimulate bone growth and support spinal fusion procedures.
MagnetOs Putty
A moldable bone graft putty that incorporates NeedleGrip surface technology to promote bone growth in spinal and orthopedic surgeries.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 5
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Kuros Biosciences Logo
Post-IPO Equity - Kuros Biosciences
4
obfuscation
venBio PartnersPost-IPO Equity
obfuscation
Post-IPO Equity - Kuros Biosciences Logo
Post-IPO Equity - Kuros Biosciences
4
obfuscation
venBio PartnersPost-IPO Equity
obfuscation
Post-IPO Equity - Kuros Biosciences Logo
Post-IPO Equity - Kuros Biosciences
4
obfuscation
venBio PartnersPost-IPO Equity
obfuscation
Post-IPO Equity - Kuros Biosciences Logo
Post-IPO Equity - Kuros Biosciences
4
obfuscation
venBio PartnersPost-IPO Equity
obfuscation
Post-IPO Equity - Kuros Biosciences Logo
Post-IPO Equity - Kuros Biosciences
4
obfuscation
venBio PartnersPost-IPO Equity

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 5
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Kuros Biosciences Logo
Post-IPO Equity - Kuros Biosciences
4
obfuscation
venBio PartnersPost-IPO Equity
obfuscation
Post-IPO Equity - Kuros Biosciences Logo
Post-IPO Equity - Kuros Biosciences
4
obfuscation
venBio PartnersPost-IPO Equity
obfuscation
Post-IPO Equity - Kuros Biosciences Logo
Post-IPO Equity - Kuros Biosciences
4
obfuscation
venBio PartnersPost-IPO Equity
obfuscation
Post-IPO Equity - Kuros Biosciences Logo
Post-IPO Equity - Kuros Biosciences
4
obfuscation
venBio PartnersPost-IPO Equity
obfuscation
Post-IPO Equity - Kuros Biosciences Logo
Post-IPO Equity - Kuros Biosciences
4
obfuscation
venBio PartnersPost-IPO Equity

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Amgen Ventures Logo
Amgen Ventures
—
Post-IPO Equity - Kuros Biosciences Logo
Post-IPO Equity - Kuros Biosciences
—
Amgen Ventures Logo
Amgen Ventures
—
Post-IPO Equity - Kuros Biosciences Logo
Post-IPO Equity - Kuros Biosciences
—
Amgen Ventures Logo
Amgen Ventures
—
Post-IPO Equity - Kuros Biosciences Logo
Post-IPO Equity - Kuros Biosciences
—
Amgen Ventures Logo
Amgen Ventures
—
Post-IPO Equity - Kuros Biosciences Logo
Post-IPO Equity - Kuros Biosciences
—
Amgen Ventures Logo
Amgen Ventures
—
Post-IPO Equity - Kuros Biosciences Logo
Post-IPO Equity - Kuros Biosciences
—
Market Intelligence
People
View Profiles & Contacts
Headcount 51-100 Employee Profiles 3 Contacts 61

Employee Profiles

News

News and Press

News•Jun 17, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 7, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 15, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Mar 10, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

5,677
-22.37%
 in past month

IT Spend

$759.5KThis year, Kuros Biosciences is projected to spend $759.5K on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
The Wall Street Journal Logo
The Wall Street Journal
66
Sub-Organizations
Frequently Asked Questions

Where is Kuros Biosciences's headquarters? Kuros Biosciences is located in Schlieren, Zurich, Switzerland.Who invested in Kuros Biosciences? Kuros Biosciences has 11 investors including Amgen Ventures and  Aisling Capital.When was the last funding round for Kuros Biosciences? Kuros Biosciences closed its last funding round on
obfuscation
from a Post-IPO Equity round.Who are Kuros Biosciences's competitors? Alternatives and possible competitors to Kuros Biosciences may include Locate Bio, Greentech Biotechnology, and  Bonegraft.How much funding has Kuros Biosciences raised to date? Kuros Biosciences has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(05b78c5 1)
|